Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Imatinib”

667 trials

Showing 20 of 667 results

Not applicableStudy completedNCT03923400
What this trial is testing

Jejunoileal vs Gastric GIST in the Era of Imatinib.

Who this might be right for
Disease-free SurvivalOverall SurvivalRecurrence
Hospital Universitario Virgen de la Arrixaca 77
Not applicableWithdrawnNCT00640692
What this trial is testing

Kinase Genotyping of Gastro Intestinal Stomach Tumors (GISTs) From Patients Enrolled in Pfizer A6181112 Phase IIIb Trial

Who this might be right for
Gastrointestinal Neoplasm
Oregon Health and Science University
Testing effectiveness (Phase 2)Study completedNCT00707408
What this trial is testing

High-Dose Imatinib for Relapsed/Refractory c-Kit Positive Acute Myelogenous Leukemia (AML)

Who this might be right for
AML
Nantes University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT01120821
What this trial is testing

Treatment of Polycythemia Vera With Gleevec

Who this might be right for
Polycythemia Vera
Weill Medical College of Cornell University 36
Testing effectiveness (Phase 2)Study completedNCT00633295
What this trial is testing

Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor

Who this might be right for
Gastrointestinal Stromal Tumors (GIST)
Novartis Pharmaceuticals 9
Early research (Phase 1)Ended earlyNCT01130688
What this trial is testing

Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.

Who this might be right for
Chronic Myelogenous Leukemia
University of Massachusetts, Worcester 2
Not applicableStudy completedNCT00386373
What this trial is testing

Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 10
Large-scale testing (Phase 3)Ended earlyNCT02627677
What this trial is testing

A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid Leukemia

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia
Ariad Pharmaceuticals 44
Testing effectiveness (Phase 2)Study completedNCT00684411
What this trial is testing

Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma

Who this might be right for
T Cell Non-Hodgkin Lymphoma
Dana-Farber Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT00618319
What this trial is testing

An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
GIST
Biogen 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07530367
What this trial is testing

Tofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Second Affiliated Hospital, Zhejiang University, School of Medicine 135
Testing effectiveness (Phase 2)Study completedNCT00112632
What this trial is testing

Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
Technical University of Munich 40
Testing effectiveness (Phase 2)Ended earlyNCT01391611
What this trial is testing

Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Kristen Ganjoo 25
Early research (Phase 1)Study completedNCT00760981
What this trial is testing

A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
David Miklos 15
Large-scale testing (Phase 3)Study completedNCT00116935
What this trial is testing

Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Sarcoma
Scandinavian Sarcoma Group 400
Testing effectiveness (Phase 2)Study completedNCT00928525
What this trial is testing

Imatinib in Patients With Desmoid Tumor and Chondrosarcoma

Who this might be right for
Advanced Desmoid TumorAdvanced Chondrosarcoma
Italian Sarcoma Group 35
Not applicableEnded earlyNCT01073436
What this trial is testing

Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha

Who this might be right for
Chronic Myeloid Leukemia
University of Michigan Rogel Cancer Center 7
Testing effectiveness (Phase 2)UnknownNCT04043676
What this trial is testing

Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Fundación Teófilo Hernando, Spain 40
Large-scale testing (Phase 3)Ended earlyNCT00519090
What this trial is testing

Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Who this might be right for
Myelogenous Leukemia
Novartis Pharmaceuticals 6
Testing effectiveness (Phase 2)UnknownNCT04416750
What this trial is testing

Positioning Imatinib for Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Imperial College London 17
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation